CIMA Sciences

CIMA Sciences is a biotechnology company that strategically brings proprietary technology to the United States, primarily focusing on developing and providing cutting-edge non-invasive diagnostic technologies for the scientific community and the U.S. population targeting high-prevalence diseases, with a particular emphasis on liver and cardiovascular risks. Recognizing the critical need for accurate and early disease detection, CIMA Sciences aims to revolutionize the diagnostics field by offering healthcare professionals breakthrough, precise, non-invasive, and accessible tools to effectively identify and manage these conditions. CIMA Sciences actively collaborates with key stakeholders in the scientific and medical communities to ensure the effective deployment of its solutions and their integration with existing healthcare systems.